2 Peninsula biotechs — including one led by Gilead's former top scientist — map out IPOs

Cancer-fighting Kronos and Spruce, targeting a serious hormonal condition, have a common investor in Omega Funds.

Source: bizjournals.com Health Care:Biotechnology headlines - September 19, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news